COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

bioRxiv posts many COVID19-related papers. A reminder: they have not been formally peer-reviewed and should not guide health-related behavior or be reported in the press as conclusive.

29,934 Articles (22,057 medRxiv, 7,877 bioRxiv)

Most recent first Previous |  Page 2736: Articles 27351-27360  | Next

Comparative transcriptome analysis reveals the intensive early-stage responses of host cells to SARS-CoV-2 infection
Sun, J., Ye, F., Wu, A., Yang, R., Pan, M., Sheng, J., Zhu, W., Mao, L., Wang, M., Huang, B., Tan, W., Jiang, T.
10.1101/2020.04.30.071274 — Posted: 2020-05-01
Dysregulation in mTOR/HIF-1 signaling identified by proteo-transcriptomics of SARS-CoV-2 infected cells
Appelberg, S., Gupta, S., Ambikan, A. T., Mikaeloff, F., Vegvari, A., Svensson Akusjarvi, S., Benfeitas, R., Sperk, M., Stahlberg, M., Krishnan, S., Singh, K., Penninger, J. M., Mirazimi, A., Neogi, U.
10.1101/2020.04.30.070383 — Posted: 2020-05-01 Discussion: Offsite
Electrostatic Characteristics of SARS-CoV-2 Spike and Human ACE2 Protein Variations Predict Mutable Binding Efficacy
Morton, S. P., Phillips, J. L.
10.1101/2020.04.30.071175 — Posted: 2020-05-01
Broad-spectrum antiviral activity of naproxen: from Influenza A to SARS-CoV-2 Coronavirus
Terrier, O., Dilly, S., Pizzorno, M.-A., Henri, J., Berenbaum, F., Lina, B., Feve, B., Adnet, F., Sabbah, M., Rosa-Calavatra, M., Marechal, V., Slama-Schwok, A.
10.1101/2020.04.30.069922 — Posted: 2020-05-01 Discussion: Onsite
COVID-19 mathematical model reopening scenarios for Sao Paulo - Brazil
Neto, O. P., Reis, J. C., Brizzi, A. C. B., Zambrano, G. J., de Souza, J. M., Amorim, W. P. E., Pedreiro, R. C. d. M., Brizzi, B. d. M., Abinader, E. O., Kennedy, D. M., Zangaro, R. A.
10.1101/2020.04.26.20081208 — Posted: 2020-05-01
Impact of mitigating interventions and temperature on the instantaneous reproduction number in the COVID-19 epidemic among 30 US metropolitan areas
Yu, X.
10.1101/2020.04.26.20081083 — Posted: 2020-05-01
Favipiravir for treating novel coronavirus (COVID-19) patients: protocol for a systematic review and meta-analysis of controlled trials
Arab-Zozani, M., Hassanipour, S., GHoddoosi-Nejad, D.
10.1101/2020.04.27.20081471 — Posted: 2020-05-01
Defining Facets of Social Distancing during the COVID-19 Pandemic: Twitter Analysis
Kwon, J., Grady, C., Feliciano, J. T., Fodeh, S. J.
10.1101/2020.04.26.20080937 — Posted: 2020-05-01
First peak of COVID-19 outbreak in Japan might pass as of April 26, 2020
Kurita, J., Sugawara, T., Ohkusa, Y.
10.1101/2020.04.26.20081315 — Posted: 2020-05-01 Discussion: Onsite
Compositional Cyber-Physical Epidemiology of COVID-19
Ro, J. W., Allen, N., Ai, W., Prasad, D., Roop, P. S.
10.1101/2020.04.26.20081125 — Posted: 2020-05-01

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).